We reviewed the sonographic, CT and angiographic findings in 19 patients with infiltrating transitional cell carcinoma of the kidney. Sonography revealed a defect of the central echo in 18 patients, and a low or slightly low echoic tumor in 15. Enhanced CT showed a poorly marginated tumor with lower attenuation than that of normal parenchyma in all 8 patients examined. Angiography showed narrowing and stretching of interlobar and arcuate arteries arranged radially from the renal hilus in all 11 patients examined and fine neovascularity in 10. These findings, especially the angiographic findings, were useful for distinguishing this disease from the common type renal cell carcinomas, and other infiltrating diseases of the kidney, such as lymphomas and sarcomas. Since the prognoses of these patients were poor with 1- and 2-year survival rates of 11.6 and 5.8%, respectively, careful examination of the above-mentioned findings was stressed to diagnose this disease.

Keywords:
Infiltrating transitional cell, carcinoma Kidney, Computerized tomography Angiography Sonography
This content is only available via PDF.
© 1994 S. Karger AG, Basel
1994
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.